Arihant Capital Markets Limited has informed the Exchange about Preferential issue

Fund Raising View source PDF Explain this filing

ARIHANTCAP · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.6%Reaction day

₹101.50

prior close

₹101.50

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.2%-0.3% vs market

Stockbroking & Allied peers, median of 33sector-1.8%+0.3% vs sector

On the reaction day the stock moved 0.3 pts less than Nifty Microcap 250 and 0.3 pts more than its Stockbroking & Allied peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.2

10m

+1.4

15m

+2.7

30m

+1.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.6-1.2-0.3-1.8+0.3

Next day

-1.1+0.3-1.3-1.2+0.2

+0.0+0.6-0.6-0.4+0.4

-1.2-0.1-1.0-1.7+0.5

-2.0-1.7-0.2-2.9+0.9

-3.9-1.2-2.7-2.7-1.2

-3.3-2.6-0.6-3.2-0.1

15d

-2.5-1.0-1.5-2.0-0.5

+8.8-3.9+12.8-6.6+15.4

+8.4-4.2+12.5-5.9+14.2

+6.2-0.7+6.9-3.2+9.4

UpDownMarket · Nifty Microcap 250Sector · Stockbroking & Allied peers, median of 33Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The Board of Arihant Capital Markets Limited has approved raising up to ₹91.35 crores by issuing up to 1.05 crore equity shares on a preferential basis to non-promoter category investors. The shares have a face value of ₹1 each and are priced at ₹87 per share, including a premium of ₹86 per share. The three allottees are Preeti Mahapatra (50 lakh shares, 4.36% post-issue holding), Harihara Mahapatra (50 lakh shares, 4.36%), and Premadevi Taparia (5 lakh shares, 0.44%), all of whom currently hold no shares in the company. An Extra-Ordinary General Meeting has been scheduled for August 21, 2025, to seek shareholder approval for the issue. The issue is subject to shareholder and other necessary regulatory approvals.

Likely market impact

Existing shareholders will face equity dilution as new investors collectively gain roughly 9.16% stake post-issue. While the capital infusion strengthens the company's capital base, the announcement does not disclose the intended use of funds, which investors should watch for in follow-up communications.